// App-Quantinova.ai

: Incidence, Clinical Associations, and Co-Mutation Patterns of UBA1 Mutations in MDS

Researchers

Presenter

  • Maria Sirenko

Principal Investigators

  • David B. Beck

  • Maria Creignou

  • Dylan Domenico

  • Andrea Farina

  • Juan E Arango

  • Olivier Kosmider

  • Robert P. Hasserjian

  • Martin Jadersten

  • Ulrich Germing

  • Guillermo Sanz

  • Arjan A. van de Loosdrecht

  • Matilde Y Follo

  • Felicitas R. Thol

  • Lurdes Zamora

  • Ronald Feitosa Pinheiro

  • Andrea Pellagatti

  • Harold K. Elias

  • Detlef Haase

  • Christina Ganster

  • Lionel Ades

  • Magnus Tobiasson

  • Laura Palomo

  • Matteo G. Della Porta

  • Kety Huberman

  • Pierre Fenaux

  • Monika Belickova

  • Michael R. Savona

  • Virginia M. Klimek

  • Fabio Pires de Souza Santos

  • Jacqueline Boultwood

  • Ioannis Kotsianidis

  • Valeria Santini

  • Francesc Sole

  • Uwe Platzbecker

  • Michael Heuser

  • Peter Valent

  • Carlo Finelli

  • Maria Teresa Voso

  • Lee-Yung Shih

  • Seishi Ogawa

  • Michaela Fontenay

  • Joop H. Jansen

  • Jose Cervera

  • Benjamin L. Ebert

  • Rafael Bejar

  • Peter L Greenberg

  • Norbert Gattermann

  • Luca Malcovati

  • Mario Cazzola

  • Eva Hellstrom-Lindberg

  • Elli Papaemmanuil

Medical Centers

  • Department of Hematology, Oncology and Clinical Immunology, Universitätsklinik Düsseldorf, Düsseldorf, Germany

  • Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

  • Department of Genomics, Institute of Hematology and Blood Transfusion, Prague, Czech Republic

  • Department of Hematology, University Hospital Vall d'Hebron, Experimental Hematology Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

  • Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan

  • Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto, Japan

  • Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA

  • Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria

  • Cancer Center, IRCCS Humanitas Research Hospital & Humanitas University, Rozzano, Italy

  • Department of Hematology, University hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece, Alexandroupolis, Greece

  • Department of Pathology, Massachusetts General Hospital, Boston, MA

  • Howard Hughes Medical Institute, Boston, MA

  • Integrated Genomics Operation, Memorial Sloan Kettering Cancer Center, New York, NY

  • Medical Clinic and Policlinic of Hematology, Cell Therapy and Hemostaseology, University Hospital Leipzig, Leipzig, Germany

  • National Institutes of Health, Bethesda, MD

  • Bloodwise Molecular Haematology Unit, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom

  • MDS Group. Institut de Recerca Contra la Leucèmia Josep Carreras (IJC), ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain

  • Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy

  • Department of Hematology, Hopital Saint Louis, Paris, France

  • Institut de Recerca contra la Leucèmia Josep Carreras, Badalona, Spain

  • Department of Hematology, Université de Paris, Saint-Louis Hospital, Paris, France

  • Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

  • Oncology-Hematology Center, Hospital Israelita Albert Einstein, Sao Paulo, SP, Brazil

  • Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY

  • Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY

  • Clinics of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany

  • Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany

  • DMSC, MDS Unit, AOU Careggi, University of Florence, Firenze, Italy

  • Dana-Farber Cancer Institute, Boston, MA

  • University of Pavia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

  • Hematology Deparment, Health Research Institute La Fe, Valencia, Spain

  • Université Paris Cité, CNRS, INSERM U, Institut Cochin, Paris, France

  • Center for Hematology and Regenerative Medicine (HERM), Department of Medicine (MedH), Karolinska Institutet, Huddinge, Sweden

  • Assistance Publique-Hôpitaux de Paris.Centre-Université Paris Cité, Hôpital Cochin, Laboratory of Hematology, Paris, France

  • Department of Clinical Medicine; Center for Research and Drug Development (NPDM), Universidade Federal do Ceará, Fortaleza, Brazil

  • Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, Netherlands

  • Center for Human Genetics and Genomics, New York University Grossman School of Medicine, New York, NY

  • Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, Bedminster, NJ

  • Laboratory of Hematology, Dept LABGK, Radboud University Medical Centre, Nijmegen, The Netherlands., Nijmegen, Netherlands

  • Center for Molecular Oncology, Center for Heme Malignancies and Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY , USA, New York, NY

  • Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan

  • Department of Hematology and Genetics Unit, Hospital Universitario La Fe, Valencia, Spain

  • Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, La Jolla, CA

  • MDS Cooperative Group GROM-L, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy

  • Department of Internal Medicine, Division of Hematology, Vanderbilt University School of Medicine; Ingram Cancer Center, Nashville, TN

  • Department of Hematology, Oncology and Clinical Immunology, Heinrich Heine University, Düsseldorf, Germany

  • Department of Molecular Medicine & Hematology Oncology, University of Pavia & IRCCS Policlinico S. Matteo Foundation, Pavia, Italy

Locations

  • Germany

  • United States

  • Italy

  • Sweden

  • Czech Republic

  • Spain

  • United Kingdom

  • Netherlands

  • Japan

  • Taiwan

  • France

  • Austria

  • Greece

  • Brazil

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • DNA methyltransferase 3 alpha

  • Tet methylcytosine dioxygenase 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved